Přihlásit se Zaregistrujte se zdarma

Návratnost kapitálu společnosti Aethlon Medical Inc

Jaká je hodnota metriky Návratnost kapitálu společnosti Aethlon Medical Inc?

Hodnota metriky Návratnost kapitálu společnosti Aethlon Medical Inc je -123.81%

Jaká je definice metriky Návratnost kapitálu?



Return on capital employed (ROCE) je finanční ukazatel, který měří rentabilitu společnosti a efektivitu společnosti ve využívání vlastního kapitálu.

Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.

ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.

Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.

Návratnost kapitálu společností v sektoru Industrials sektor na NASDAQ ve srovnání se společností Aethlon Medical Inc

Čemu se věnuje společnost Aethlon Medical Inc?

the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.

Firmy s metrikou návratnost kapitálu podobnou společnosti Aethlon Medical Inc